CIPA Congress 2015: GSK will decide on ‘case-by-case’ basis which patents to opt into UPC

02-10-2015

CIPA Congress 2015: GSK will decide on ‘case-by-case’ basis which patents to opt into UPC

360b / Shutterstock.com

Representatives from the pharmaceutical and engineering industries have said that the decision to opt existing patents into the Unified Patent Court (UPC) will be a strategic decision done on a case-by-case basis.


CIPA; UPC; GSK; BAe; patents; pharmaceuticals; engineering; NPEs

LSIPR